Research Options:

Week of Expected Pricing 4/16/2021
Company Name RECURSION PHARMACEUTICALS INC
Proposed Ticker RXRX
CUSIP 75629V104
Business Description A clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what we believe is one of the world’s largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate our programs. The combination of wet-lab biology and in silico tools in our closed-loop system differentiates us from others within the industry.
Lead Underwriter Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC
Co-Managers Allen & Company LLC, BofA Securities, Inc, KeyBanc Capital Markets Inc, SVB Leerink LLC
Initial Shares 1,80,00,000
Revised Initial Shares 2,42,42,424
Initial Price $16.00-$18.00
Revised Price N/A
Final Price $18.00
Final Ticker RXRX

 

 

   
  © 2024 ICE Data Services. All rights reserved.